Gujarat Kidney And Superspeciality Schedules Board Meeting for Q2 FY27 Results
Gujarat Kidney and Super Speciality Ltd 路 Intimation 路 04 Nov 2026, 5:30 am
Gujarat Kidney And Superspeciality Schedules Board Meeting for Q2 FY27 Results Gujarat Kidney And Superspeciality Limited will convene its Board of Directors meeting on 4th Nov'26 to consider and approve the unaudited standalone and consolidated financial results for the quarter ended 30th Sep'26. In compliance with insider trading regulations, the company's trading window for designated persons and immediate relatives has been closed effective 1st Oct'26 and will remain shut until 48 hours following the declaration of the financial results.
Original exchange filing (PDF)
More announcements from Gujarat Kidney and Super Speciality Ltd
- Transcript of Earning Call conducted on 05/11/2026 路 11 Nov 2026
- Audio recording of earning call 路 05 Nov 2026
- Revised presentation Uploaded for today''s Earning Con-Call. 路 05 Nov 2026
- Investor Presentation for scheduled Conference Call on November 05, 2026 路 05 Nov 2026
- Statement of Deviation and Variation submitted for the quarter ended on September 30, 2026. 路 05 Nov 2026
- Monitoring Report for the Quarter ended September 30, 2026 路 05 Nov 2026
- Unaudited Standalone and Consolidated Financial Results for the Quarter ended September 30, 2026 路 05 Nov 2026
- Gujarat Kidney And Super Speciality Limited has submitted to the Exchange, the unaudited Standalone and Consolidated financial results for the period ended September 30, 2026. 路 05 Nov 2026
